赛托瑞疗法(CYTX)

0.2077 0.0000 0.0%

今开:0.0昨收:0.2077
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:4601759.0

赛托瑞疗法的热门评论

赛托瑞疗法(CYTX)2019-08-15 11:50

$赛托瑞疗法(CYTX)$ NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB Filed: 2019-08-14 AccNo: 0001564590-19-032183 Size: 63 KB 网页链接查看全文

赛托瑞疗法(CYTX)2019-08-10 05:10

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-09 AccNo: 0001564590-19-031278 Size: 32 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接查看全文

赛托瑞疗法(CYTX)2019-08-03 04:15

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-02 AccNo: 0001564590-19-028357 Size: 35 KBItem 7.01: Regulation FD Disclosure 网页链接查看全文

赛托瑞疗法(CYTX)2019-08-16 05:40

$赛托瑞疗法(CYTX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-15 AccNo: 0001564590-19-032349 Size: 6 MB 网页链接查看全文

赛托瑞疗法(CYTX)2019-07-29 20:20

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-29 AccNo: 0001564590-19-026454 Size: 249 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接查看全文

静心成佛2019-08-02 22:43

$赛托瑞疗法(CYTX)$ 发生什么了?查看全文

赛托瑞疗法(CYTX)2019-08-06 20:15

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001564590-19-028996 Size: 53 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接查看全文

赛托瑞疗法(CYTX)2019-07-23 20:20

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-23 AccNo: 0001564590-19-025505 Size: 37 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接查看全文

赛托瑞疗法(CYTX)2019-06-28 06:10

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-06-27 AccNo: 0001564590-19-023871 Size: 39 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68

赛托瑞疗法的最新评论

牛得草2014-06-26 22:08

$赛托瑞医疗(CYTX)$磨磨唧唧想干啥,一天没几分钱的波动,不涨不跌。查看全文

szmayun2014-06-24 11:36

回复@laxmipriya: 时间成本同样宝贵,要联系仓位组合衡量耐心与否,赛托瑞目前不是我重仓品种,之所以没有重仓就是出于对时间成本的考虑[赞成]//@laxmipriya:回复@szmayun:[鼓鼓掌]好有耐心的人啊!查看全文

szmayun2014-06-24 10:42

$赛托瑞医疗(CYTX)$不积跬步,无以至千里,西班牙巴塞罗那运动损伤及韧带修复一期临床试验受试患者完成报名,是CYTX大平台多项目中的一项漫长试验中的一个跬步。CYTX目前还处于垃圾时间和股价随机漫步阶段,但是,在悄悄酝酿多维、重大因素共振爆发的契机,由于想象空间十分巨大,值得耐心等待。@...查看全文

dotknot2014-06-23 23:13

$赛托瑞医疗(CYTX)$万红丛中一点绿[滴汗]查看全文

豆豆作坊2014-06-21 15:17

$赛托瑞医疗(CYTX)$ 我的证券公司让投票,是什么意思?查看全文

唯一色彩_832014-06-20 12:35

关于$赛托瑞医疗(CYTX)$,对@牛得草 说: 牛兄,欧洲FDA的临床结果大概什么时候能出呢查看全文

利欧一桶金2014-06-19 10:41

$冠昊生物(SZ300238)$果断买入在国内它算是相当不错的医疗股票了!虽然比不上我的$赛托瑞医疗(CYTX)$中线持有![想一下]赚点小钱然后继续加仓美股$赛托瑞医疗(CYTX)$[摊手]查看全文

牛得草2014-06-12 07:12

$赛托瑞医疗(CYTX)$ Investor Note: Cytori Completes BARDA In-Process Review Meeting06/11/2014Dear Investors:Cytori has completed an In-Process Review (IPR) meeting with the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Hea...查看全文

dotknot2014-06-02 22:22

$赛托瑞医疗(CYTX)$ 一点量也没有,想买买不到,想卖卖不出,所以没有量的存在,价钱确实也就没有意义。今天好不容易加仓买入了一部分,不知不觉发现好像已经买了不少了[滴汗]原来买股票也能越来越上瘾啊,今天是我最后一笔买入cytx,记录一下,提醒自己。查看全文

牛得草2014-05-30 21:51

$赛托瑞医疗(CYTX)$终于放量了查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68

赛托瑞疗法的公告

$赛托瑞疗法(CYTX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-15 AccNo: 0001564590-19-032349 Size: 6 MB 网页链接

$赛托瑞疗法(CYTX)$ NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB Filed: 2019-08-14 AccNo: 0001564590-19-032183 Size: 63 KB 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-09 AccNo: 0001564590-19-031278 Size: 32 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001564590-19-028996 Size: 53 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-02 AccNo: 0001564590-19-028357 Size: 35 KBItem 7.01: Regulation FD Disclosure 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-29 AccNo: 0001564590-19-026454 Size: 249 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-23 AccNo: 0001564590-19-025505 Size: 37 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-16 AccNo: 0001564590-19-025075 Size: 57 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-11 AccNo: 0001564590-19-024844 Size: 64 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission o...

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-05 AccNo: 0001564590-19-024571 Size: 40 KBItem 2.05: Cost Associated with Exit or Disposal ActivitiesItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensat...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37